Filgrastim
2097.00
Phase 1 mab terminated
Quick answer
Filgrastim for Fanconi Anemia is a Phase 1 program (mab) at ROCKET PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ROCKET PHARMACEUTICALS, INC.
- Indication
- Fanconi Anemia
- Phase
- Phase 1
- Modality
- mab
- Status
- terminated